000 01179nam a2200325 a 4500
005 20250918145319.0
008 110922s2011 gw a b 001 0 eng c
020 _a9783527327317
_cRM457.38
020 _a3527327312
039 9 _a201111091248
_bzainol
_y09-22-2011
_zrazalis
040 _aUKM
060 _aQV744
_b.A642 2011 9
090 _aQV744.A642 2011 9
245 0 0 _aApicomplexan parasites :
_bmolecular approaches toward targeted drug development /
_cedited by Katja Becker
260 _aWeinheim :
_bWiley-Blackwell,
_c2011
300 _axxi, 528 p. :
_bill. (some col.)
490 _aDrug discovery in infectious diseases ;
_vv. 2
650 2 _aAntiprotozoal Agents
_xtherapeutic use
650 2 _aApicomplexa
_ximmunology
650 2 _aProtozoan Infections
_xdrug therapy
650 2 _aProtozoan Vaccines
_xtherapeutic use
700 1 _aBecker, Katja,
_d1965-
830 0 _aDrug discovery in infectious diseases ;
_vv. 2
907 _a.b15161705
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV744.A642 2011 9
914 _avtls003479270
991 _aJabatan Farmasi, KKL
998 _ad
_b2011-09-09
_cm
_da
_feng
_ggw
_y0
_z.b15161705
999 _c500419
_d500419